Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review

Alopecia areata (AA) is a patchy autoimmune nonscarring hair loss. Various pathophysiological explanations are described with immune dysregulation being the most well established. In this report, we describe a 63-year-old lady with AA recurrence, in the form of AA universalis, after 32 years of remi...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdalla, Hani, Ebrahim, Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375056/
https://www.ncbi.nlm.nih.gov/pubmed/35975094
http://dx.doi.org/10.7759/cureus.27953
_version_ 1784767877072551936
author Abdalla, Hani
Ebrahim, Ebrahim
author_facet Abdalla, Hani
Ebrahim, Ebrahim
author_sort Abdalla, Hani
collection PubMed
description Alopecia areata (AA) is a patchy autoimmune nonscarring hair loss. Various pathophysiological explanations are described with immune dysregulation being the most well established. In this report, we describe a 63-year-old lady with AA recurrence, in the form of AA universalis, after 32 years of remission, following administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. We also briefly reviewed published cases with similar presentations after receiving the SARS-CoV-2 vaccine.
format Online
Article
Text
id pubmed-9375056
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-93750562022-08-15 Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review Abdalla, Hani Ebrahim, Ebrahim Cureus Dermatology Alopecia areata (AA) is a patchy autoimmune nonscarring hair loss. Various pathophysiological explanations are described with immune dysregulation being the most well established. In this report, we describe a 63-year-old lady with AA recurrence, in the form of AA universalis, after 32 years of remission, following administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. We also briefly reviewed published cases with similar presentations after receiving the SARS-CoV-2 vaccine. Cureus 2022-08-12 /pmc/articles/PMC9375056/ /pubmed/35975094 http://dx.doi.org/10.7759/cureus.27953 Text en Copyright © 2022, Abdalla et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Abdalla, Hani
Ebrahim, Ebrahim
Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
title Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
title_full Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
title_fullStr Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
title_full_unstemmed Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
title_short Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
title_sort alopecia areata universalis precipitated by sars-cov-2 vaccine: a case report and narrative review
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375056/
https://www.ncbi.nlm.nih.gov/pubmed/35975094
http://dx.doi.org/10.7759/cureus.27953
work_keys_str_mv AT abdallahani alopeciaareatauniversalisprecipitatedbysarscov2vaccineacasereportandnarrativereview
AT ebrahimebrahim alopeciaareatauniversalisprecipitatedbysarscov2vaccineacasereportandnarrativereview

Ejemplares similares